Lucía Gandarias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lucía Gandarias has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Maria Luisa Fernández-Gubieda
Dpto. Electricidad y Electrónica Universidad del País Vasco – UPV/EHU Leioa Spain
8 shared publications - Javier Alonso
Department CITIMAC, Faculty of Sciences, University of Cantabria, 39005 Santander, Spain
6 shared publications - Alicia G. Gubieda
Dpto. Inmunología Microbiología y Parasitología Universidad del País Vasco – UPV/EHU Leioa Spain
5 shared publications - Ana Abad-Diaz-De-Cerio
Department of Immunology, Microbiology and Parasitology University of the Basque Country (UPV/EHU) Leioa Bizkaia Spain
5 shared publications Alicia Muela
Dpto. Inmunología, Microbiología y Parasitología, Universidad del País Vasco (UPV/EHU), Leioa, 48940, Spain
4 shared publications- Ana García-Prieto
Departamento de Física Aplicada Universidad del País Vasco (UPV/EHU) Bilbao Spain
4 shared publications
Latest Publications
- Open Access
Identifying the internalization pathways of magnetotactic bacteria and magnetosomes by cancer cells
Given the need for new tumor treatment strategies, therapies using magnetic nanoparticles and bacteria are gaining momentum. In this context, magnetotactic bacteria and magnetosomes could act as theranostic agents for use in magnetic hyperthermia, targeted drug delivery, and magnetic resonance imaging. Thus, understanding their interaction with target cells is essential to ensure their theranostic efficiency. This study investigates the uptake of magnetotactic bacteria (MSR-1) and magnetosomes by lung carcinoma cells (A549). First, MSR-1 and magnetosomes are imaged inside A549 cells using cryo soft X-ray tomography, revealing the presence of MSR-1 and magnetosomes inside endosomes. Subsequently, the endocytosis pathways involved in the internalization of MSR-1 and magnetosomes by the cells are elucidated. It is observed that MSR-1 mainly enter cells by receptor-mediated endocytosis, as described previously for other intracellular bacteria. However, the endocytosis of magnetosomes occurs mainly via phagocytosis or macropinocytosis, probably due to the large size of the formed magnetosome clusters. These findings fill a key gap in our understanding of the internalization of MSR-1 bacteria and magnetosomes by lung carcinoma cells, and establish a method applicable to studying their internalization by other target cell types. Graphical Magnetotactic bacteria ( Magnetospirillum gryphiswaldense MSR-1) and magnetosomes, which are proposed as cancer theranostic mediators, are imaged inside A549 cancer cells in 3D using cryo soft X-ray tomography. Moreover, the endocytosis pathways that the cells use to internalize MSR-1 and magnetosomes are elucidated. MSR-1 predominantly enter A549 cells via receptor-mediated endocytosis, while magnetosomes are preferentially internalized via receptor-independent endocytosis.
Open AccessIdentifying the internalization pathways of magnetotactic bacteria and magnetosomes by cancer cells
Given the need for new tumor treatment strategies, therapies using magnetic nanoparticles and bacteria are gaining momentum. In this context, magnetotactic bacteria and magnetosomes could act as theranostic agents for use in magnetic hyperthermia, targeted drug delivery, and magnetic resonance imaging. Thus, understanding their interaction with target cells is essential to ensure their theranostic efficiency. This study investigates the uptake of magnetotactic bacteria (MSR-1) and magnetosomes by lung carcinoma cells (A549). First, MSR-1 and magnetosomes are imaged inside A549 cells using cryo soft X-ray tomography, revealing the presence of MSR-1 and magnetosomes inside endosomes. Subsequently, the endocytosis pathways involved in the internalization of MSR-1 and magnetosomes by the cells are elucidated. It is observed that MSR-1 mainly enter cells by receptor-mediated endocytosis, as described previously for other intracellular bacteria. However, the endocytosis of magnetosomes occurs mainly via phagocytosis or macropinocytosis, probably due to the large size of the formed magnetosome clusters. These findings fill a key gap in our understanding of the internalization of MSR-1 bacteria and magnetosomes by lung carcinoma cells, and establish a method applicable to studying their internalization by other target cell types. Graphical Magnetotactic bacteria ( Magnetospirillum gryphiswaldense MSR-1) and magnetosomes, which are proposed as cancer theranostic mediators, are imaged inside A549 cancer cells in 3D using cryo soft X-ray tomography. Moreover, the endocytosis pathways that the cells use to internalize MSR-1 and magnetosomes are elucidated. MSR-1 predominantly enter A549 cells via receptor-mediated endocytosis, while magnetosomes are preferentially internalized via receptor-independent endocytosis.
- Open Access
- 20 November 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (45) , 26203-26213
Micromagnetic structure of oxidized magnetite nanoparticles: sharp structural versus diffuse magnetic interface
The oxidation of magnetite to maghemite is a naturally occurring process that leads to the degradation of the magnetic properties of magnetite nanoparticles.
- 20 November 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (45) , 26203-26213
Open AccessMicromagnetic structure of oxidized magnetite nanoparticles: sharp structural versus diffuse magnetic interface
The oxidation of magnetite to maghemite is a naturally occurring process that leads to the degradation of the magnetic properties of magnetite nanoparticles.
- Open Access
- 14 April 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (16) , 16061-16072
Exploring the Complex Interplay of Anisotropies in Magnetosomes of Magnetotactic Bacteria
Magnetotactic bacteria (MTB) are at the forefront of interest for biophysics applications, especially in cancer treatment. Magnetosomes biomineralized by these bacteria are high-quality magnetic nanoparticles that form chains inside the MTB through a highly reproducible, naturally driven process. In particular, Magnetovibrio blakemorei and Magnetospirillum gryphiswaldense MTB exhibit distinct magnetosome morphologies: truncated hexa-octahedral and cuboctahedral shapes, respectively. Despite having identical compositions (magnetite, Fe3O4) and dimensions within a similar size range, their effective uniaxial anisotropies significantly differ at room temperature, with M. blakemorei exhibiting ∼25 kJ/m3 and M. gryphiswaldense ∼ 11 kJ/m3. This prominent anisotropy variance provides a unique opportunity to explore the role of magnetic anisotropy contributions in the magnetic responses of these magnetite-based nanoparticles. This study systematically investigates these responses by examining static magnetization as a function of temperature (M vs T, 5 mT) and magnetic field (M vs μ0 H, up to 1 T). Above the Verwey transition temperature (∼110 K), the effective anisotropy is dominated by the shape anisotropy contribution, notably increasing the coercivity for M. blakemorei by up to twofold compared to M. gryphiswaldense. However, below this temperature, the effective uniaxial anisotropy rapidly increases in a nonmonotonic way, significantly changing the magnetic behavior. Computational simulations using a dynamic Stoner-Wohlfarth model provide insights into these phenomena, enabling careful interpretation of experimental data. According to our simulations, below the Verwey temperature, a uniaxial magnetocrystalline contribution progressively emerges, peaking around 22-24 kJ/m3 at 5 K. Our study reveals the complex evolution of magnetocrystalline contributions, which dominate the magnetic response of magnetosomes below the Verwey temperature. This demonstrates the profound impact of anisotropic properties on the magnetic behaviors and applications of magnetite-based nanoparticles and highlights the exceptional utility of magnetosomes as ideal model systems for studying the complex interplay of anisotropies in magnetite-based nanoparticles.
- 14 April 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (16) , 16061-16072
Open AccessExploring the Complex Interplay of Anisotropies in Magnetosomes of Magnetotactic Bacteria
Magnetotactic bacteria (MTB) are at the forefront of interest for biophysics applications, especially in cancer treatment. Magnetosomes biomineralized by these bacteria are high-quality magnetic nanoparticles that form chains inside the MTB through a highly reproducible, naturally driven process. In particular, Magnetovibrio blakemorei and Magnetospirillum gryphiswaldense MTB exhibit distinct magnetosome morphologies: truncated hexa-octahedral and cuboctahedral shapes, respectively. Despite having identical compositions (magnetite, Fe3O4) and dimensions within a similar size range, their effective uniaxial anisotropies significantly differ at room temperature, with M. blakemorei exhibiting ∼25 kJ/m3 and M. gryphiswaldense ∼ 11 kJ/m3. This prominent anisotropy variance provides a unique opportunity to explore the role of magnetic anisotropy contributions in the magnetic responses of these magnetite-based nanoparticles. This study systematically investigates these responses by examining static magnetization as a function of temperature (M vs T, 5 mT) and magnetic field (M vs μ0 H, up to 1 T). Above the Verwey transition temperature (∼110 K), the effective anisotropy is dominated by the shape anisotropy contribution, notably increasing the coercivity for M. blakemorei by up to twofold compared to M. gryphiswaldense. However, below this temperature, the effective uniaxial anisotropy rapidly increases in a nonmonotonic way, significantly changing the magnetic behavior. Computational simulations using a dynamic Stoner-Wohlfarth model provide insights into these phenomena, enabling careful interpretation of experimental data. According to our simulations, below the Verwey temperature, a uniaxial magnetocrystalline contribution progressively emerges, peaking around 22-24 kJ/m3 at 5 K. Our study reveals the complex evolution of magnetocrystalline contributions, which dominate the magnetic response of magnetosomes below the Verwey temperature. This demonstrates the profound impact of anisotropic properties on the magnetic behaviors and applications of magnetite-based nanoparticles and highlights the exceptional utility of magnetosomes as ideal model systems for studying the complex interplay of anisotropies in magnetite-based nanoparticles.
- Open Access
- 3 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (26) , 12068-12079
Imaging biomineralizing bacteria in their native-state with X-ray fluorescence microscopy
Using synchrotron nanobeam X-ray fluorescence microscopy with a liquid cell, intracellular iron is quantified in hydrated magnetotactic bacteria, and magnetite biomineralization is tracked in situ, advancing metal imaging in biological systems.
- 3 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (26) , 12068-12079
Open AccessImaging biomineralizing bacteria in their native-state with X-ray fluorescence microscopy
Using synchrotron nanobeam X-ray fluorescence microscopy with a liquid cell, intracellular iron is quantified in hydrated magnetotactic bacteria, and magnetite biomineralization is tracked in situ, advancing metal imaging in biological systems.
- Open Access
Chemical coupling of biological magnetosomes with amine-functionalized therapeutic antibody conjugates
Background: Immunotherapy, particularly in cancer treatment, can be enhanced using antibody-drug or antibody-radionuclide conjugates. These conjugates disrupt cell signaling and induce cell death, requiring the targeted antigen to be highly expressed on tumor cells to avoid damage to healthy tissues. A promising strategy to improve delivery is the use of magnetosomes, biological magnetic nanoparticles, which can be guided to tumor sites using magnetic fields. However, most antibody-drug or antibody-radionuclide conjugates are functionalized using the antibody amine groups of the lysine residues on the heavy chains. Therefore, these amine groups are no longer available to bind the antibodies to the magnetosomes. Results: Here, we explore an alternative approach to bind amine-functionalized antibodies to magnetosomes. Using SulfoSuccinimidyl-4-(N-Maleimidomethyl)Cyclohexane-1-Carboxylate (S-SMCC) as a crosslinker, the antibodies are chemically attached to the magnetosome membrane via thiol groups through antibody partial reduction. Our results demonstrate that this chemical process preserves the integrity and functionality of both magnetosomes and antibodies. Moreover, we prove that the produced magnetosome-antibody conjugates are stable under various in vivo -like conditions. Conclusion: This coupling method offers significant advantages, enabling the coupling of therapeutic molecules to antibodies combined with the magnetic properties of magnetosomes. This new strategy aims to improve cancer therapy through targeted delivery and rapid accumulation at tumor sites.
Open AccessChemical coupling of biological magnetosomes with amine-functionalized therapeutic antibody conjugates
Background: Immunotherapy, particularly in cancer treatment, can be enhanced using antibody-drug or antibody-radionuclide conjugates. These conjugates disrupt cell signaling and induce cell death, requiring the targeted antigen to be highly expressed on tumor cells to avoid damage to healthy tissues. A promising strategy to improve delivery is the use of magnetosomes, biological magnetic nanoparticles, which can be guided to tumor sites using magnetic fields. However, most antibody-drug or antibody-radionuclide conjugates are functionalized using the antibody amine groups of the lysine residues on the heavy chains. Therefore, these amine groups are no longer available to bind the antibodies to the magnetosomes. Results: Here, we explore an alternative approach to bind amine-functionalized antibodies to magnetosomes. Using SulfoSuccinimidyl-4-(N-Maleimidomethyl)Cyclohexane-1-Carboxylate (S-SMCC) as a crosslinker, the antibodies are chemically attached to the magnetosome membrane via thiol groups through antibody partial reduction. Our results demonstrate that this chemical process preserves the integrity and functionality of both magnetosomes and antibodies. Moreover, we prove that the produced magnetosome-antibody conjugates are stable under various in vivo -like conditions. Conclusion: This coupling method offers significant advantages, enabling the coupling of therapeutic molecules to antibodies combined with the magnetic properties of magnetosomes. This new strategy aims to improve cancer therapy through targeted delivery and rapid accumulation at tumor sites.
- Open Access
- 26 December 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Imaging biomineralizing bacteria in the native-state with X-ray fluorescence microscopy
Understanding the interactions between metal-based nanoparticles and biological systems in complex environments (e.g., the human body, soils, and marine settings) remains challenging, especially at the single-cell and nanoscale levels. Capturing the dynamics of these interactions, such as metal distribution, nanoparticle growth, and degradation, in their native state (in vivo) is particularly difficult. Here, we demonstrate the direct measurement of iron content in hydrated, magnetite-biomineralizing magnetotactic bacteria using synchrotron-based X-ray nanobeam scanning fluorescence microscopy combined with a liquid cell environment. In addition to X-ray fluorescence imaging, we collected iron chemical speciation information from individual bacteria in liquid using X-ray absorption spectroscopy. For in situ biomineralization studies, we developed a microfluidic device to track magnetite nanoparticle formation over several hours under the X-ray beam. This approach highlights the potential of X-ray fluorescence microscopy in liquid cell setups to provide elemental and chemical insights into biological processes at the single-cell level. Combining X-ray nanobeam techniques with liquid cell devices will enable more “on-chip” experiments on metals in biological contexts to be conducted at the synchrotron.
- 26 December 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessImaging biomineralizing bacteria in the native-state with X-ray fluorescence microscopy
Understanding the interactions between metal-based nanoparticles and biological systems in complex environments (e.g., the human body, soils, and marine settings) remains challenging, especially at the single-cell and nanoscale levels. Capturing the dynamics of these interactions, such as metal distribution, nanoparticle growth, and degradation, in their native state (in vivo) is particularly difficult. Here, we demonstrate the direct measurement of iron content in hydrated, magnetite-biomineralizing magnetotactic bacteria using synchrotron-based X-ray nanobeam scanning fluorescence microscopy combined with a liquid cell environment. In addition to X-ray fluorescence imaging, we collected iron chemical speciation information from individual bacteria in liquid using X-ray absorption spectroscopy. For in situ biomineralization studies, we developed a microfluidic device to track magnetite nanoparticle formation over several hours under the X-ray beam. This approach highlights the potential of X-ray fluorescence microscopy in liquid cell setups to provide elemental and chemical insights into biological processes at the single-cell level. Combining X-ray nanobeam techniques with liquid cell devices will enable more “on-chip” experiments on metals in biological contexts to be conducted at the synchrotron.
- Open Access
- 26 November 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (49) , 67216-67224
Heating Efficiency of Different Magnetotactic Bacterial Species: Influence of Magnetosome Morphology and Chain Arrangement
Magnetotactic bacteria have been proposed as ideal biological nanorobots due to the presence of an intracellular chain of magnetic nanoparticles (MNPs), which allows them to be guided and controlled by external magnetic fields and provides them with theragnostic capabilities intrinsic to magnetic nanoparticles, such as magnetic hyperthermia for cancer treatment. Here, we study three different bacterial species, Magnetospirillum gryphiswaldense (MSR-1), Magnetospirillum magneticum (AMB-1), and Magnetovibrio blakemorei (MV-1), which synthesize magnetite nanoparticles with different morphologies and chain arrangements. We analyzed the impact of these parameters on the effective magnetic anisotropy, Keff, and the heating capacity or Specific Absorption Rate, SAR, under alternating magnetic fields. SAR values have been obtained from the area of experimental AC hysteresis loops, while Keff has been determined from simulations of AC hysteresis loops using a dynamic Stoner-Wohlfarth model. The results demonstrate a clear relationship between the effective magnetic anisotropy and the heating efficiency of bacteria. As the Keff value increases, the saturated SAR values are higher; however, the threshold magnetic field required to observe a SAR response simultaneously increases. This factor is crucial to choose a bacterial species as the optimal hyperthermia agent.
- 26 November 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (49) , 67216-67224
Open AccessHeating Efficiency of Different Magnetotactic Bacterial Species: Influence of Magnetosome Morphology and Chain Arrangement
Magnetotactic bacteria have been proposed as ideal biological nanorobots due to the presence of an intracellular chain of magnetic nanoparticles (MNPs), which allows them to be guided and controlled by external magnetic fields and provides them with theragnostic capabilities intrinsic to magnetic nanoparticles, such as magnetic hyperthermia for cancer treatment. Here, we study three different bacterial species, Magnetospirillum gryphiswaldense (MSR-1), Magnetospirillum magneticum (AMB-1), and Magnetovibrio blakemorei (MV-1), which synthesize magnetite nanoparticles with different morphologies and chain arrangements. We analyzed the impact of these parameters on the effective magnetic anisotropy, Keff, and the heating capacity or Specific Absorption Rate, SAR, under alternating magnetic fields. SAR values have been obtained from the area of experimental AC hysteresis loops, while Keff has been determined from simulations of AC hysteresis loops using a dynamic Stoner-Wohlfarth model. The results demonstrate a clear relationship between the effective magnetic anisotropy and the heating efficiency of bacteria. As the Keff value increases, the saturated SAR values are higher; however, the threshold magnetic field required to observe a SAR response simultaneously increases. This factor is crucial to choose a bacterial species as the optimal hyperthermia agent.
- Open Access
- 5 November 2024
- Published by IOP Publishing in Nanotechnology
- Vol. 36 (4) , 042003
Roadmap on magnetic nanoparticles in nanomedicine
Magnetic nanoparticles (MNPs) represent a class of small particles typically with diameters ranging from 1 to 100 nanometers. These nanoparticles are composed of magnetic materials such as iron, cobalt, nickel, or their alloys. The nanoscale size of MNPs gives them unique physicochemical (physical and chemical) properties not found in their bulk counterparts. Their versatile nature and unique magnetic behavior make them valuable in a wide range of scientific, medical, and technological fields. Over the past decade, there has been a significant surge in MNP-based applications spanning biomedical uses, environmental remediation, data storage, energy storage, and catalysis. Given their magnetic nature and small size, MNPs can be manipulated and guided using external magnetic fields. This characteristic is harnessed in biomedical applications, where these nanoparticles can be directed to specific targets in the body for imaging, drug delivery, or hyperthermia treatment. Herein, this roadmap offers an overview of the current status, challenges, and advancements in various facets of MNPs. It covers magnetic properties, synthesis, functionalization, characterization, and biomedical applications such as sample enrichment, bioassays, imaging, hyperthermia, neuromodulation, tissue engineering, and drug/gene delivery. However, as MNPs are increasingly explored for in vivo applications, concerns have emerged regarding their cytotoxicity, cellular uptake, and degradation, prompting attention from both researchers and clinicians. This roadmap aims to provide a comprehensive perspective on the evolving landscape of MNP research.
- 5 November 2024
- Published by IOP Publishing in Nanotechnology
- Vol. 36 (4) , 042003
Open AccessRoadmap on magnetic nanoparticles in nanomedicine
Magnetic nanoparticles (MNPs) represent a class of small particles typically with diameters ranging from 1 to 100 nanometers. These nanoparticles are composed of magnetic materials such as iron, cobalt, nickel, or their alloys. The nanoscale size of MNPs gives them unique physicochemical (physical and chemical) properties not found in their bulk counterparts. Their versatile nature and unique magnetic behavior make them valuable in a wide range of scientific, medical, and technological fields. Over the past decade, there has been a significant surge in MNP-based applications spanning biomedical uses, environmental remediation, data storage, energy storage, and catalysis. Given their magnetic nature and small size, MNPs can be manipulated and guided using external magnetic fields. This characteristic is harnessed in biomedical applications, where these nanoparticles can be directed to specific targets in the body for imaging, drug delivery, or hyperthermia treatment. Herein, this roadmap offers an overview of the current status, challenges, and advancements in various facets of MNPs. It covers magnetic properties, synthesis, functionalization, characterization, and biomedical applications such as sample enrichment, bioassays, imaging, hyperthermia, neuromodulation, tissue engineering, and drug/gene delivery. However, as MNPs are increasingly explored for in vivo applications, concerns have emerged regarding their cytotoxicity, cellular uptake, and degradation, prompting attention from both researchers and clinicians. This roadmap aims to provide a comprehensive perspective on the evolving landscape of MNP research.
- Open Access
- 24 May 2023
- Published by Elsevier in Materials Today Bio
- Vol. 20, 100680
Incorporation of Tb and Gd improves the diagnostic functionality of magnetotactic bacteria
- 24 May 2023
- Published by Elsevier in Materials Today Bio
- Vol. 20, 100680
Open AccessIncorporation of Tb and Gd improves the diagnostic functionality of magnetotactic bacteria
- Open Access
Intracellular biotransformation and disposal mechanisms of magnetosomes in macrophages and cancer cells
Magnetosomes are magnetite nanoparticles biosynthesized by magnetotactic bacteria. Given their potential clinical applications for the diagnosis and treatment of cancer, it is essential to understand what becomes of them once they are within the body. With this aim, here we have followed the intracellular long-term fate of magnetosomes in two cell types: cancer cells (A549 cell line), because they are the actual target for the therapeutic activity of the magnetosomes, and macrophages (RAW 264.7 cell line), because of their role at capturing foreign agents. We show that cells dispose of magnetosomes using three mechanisms: splitting them into daughter cells, excreting them to the surrounding environment, and degrading them yielding less or non-magnetic iron products. A deeper insight into the degradation mechanisms by means of time-resolved X-ray absorption near-edge structure (XANES) spectroscopy has allowed us to follow the intracellular biotransformation of magnetosomes by identifying and quantifying the iron species occurring during the process. In both cell types there is a first oxidation of magnetite to maghemite and then, earlier in macrophages than in cancer cells, ferrihydrite starts to appear. Given that ferrihydrite is the iron mineral phase stored in the cores of ferritin proteins, this suggests that cells use the iron released from the degradation of magnetosomes to load ferritin. Comparison of both cellular types evidences that macrophages are more efficient at disposing of magnetosomes than cancer cells, attributed to their role in degrading external debris and in iron homeostasis. Graphical
Open AccessIntracellular biotransformation and disposal mechanisms of magnetosomes in macrophages and cancer cells
Magnetosomes are magnetite nanoparticles biosynthesized by magnetotactic bacteria. Given their potential clinical applications for the diagnosis and treatment of cancer, it is essential to understand what becomes of them once they are within the body. With this aim, here we have followed the intracellular long-term fate of magnetosomes in two cell types: cancer cells (A549 cell line), because they are the actual target for the therapeutic activity of the magnetosomes, and macrophages (RAW 264.7 cell line), because of their role at capturing foreign agents. We show that cells dispose of magnetosomes using three mechanisms: splitting them into daughter cells, excreting them to the surrounding environment, and degrading them yielding less or non-magnetic iron products. A deeper insight into the degradation mechanisms by means of time-resolved X-ray absorption near-edge structure (XANES) spectroscopy has allowed us to follow the intracellular biotransformation of magnetosomes by identifying and quantifying the iron species occurring during the process. In both cell types there is a first oxidation of magnetite to maghemite and then, earlier in macrophages than in cancer cells, ferrihydrite starts to appear. Given that ferrihydrite is the iron mineral phase stored in the cores of ferritin proteins, this suggests that cells use the iron released from the degradation of magnetosomes to load ferritin. Comparison of both cellular types evidences that macrophages are more efficient at disposing of magnetosomes than cancer cells, attributed to their role in degrading external debris and in iron homeostasis. Graphical